216 related articles for article (PubMed ID: 38707833)
1. How Does ADPKD Severity Differ Between Family Members?
Yeung KC; Fryml E; Lanktree MB
Kidney Int Rep; 2024 May; 9(5):1198-1209. PubMed ID: 38707833
[TBL] [Abstract][Full Text] [Related]
2. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T
JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973
[TBL] [Abstract][Full Text] [Related]
3. Polygenic risk affects the penetrance of monogenic kidney disease.
Khan A; Shang N; Nestor JG; Weng C; Hripcsak G; Harris PC; Gharavi AG; Kiryluk K
medRxiv; 2023 May; ():. PubMed ID: 37214819
[TBL] [Abstract][Full Text] [Related]
4. Familial Variability of Disease Severity in Adult Patients With ADPKD.
Elhassan EAE; O'Kelly P; Collins KE; Teltsh O; Ciurli F; Murray SL; Kennedy C; Madden SF; Benson KA; Cavalleri GL; Conlon PJ
Kidney Int Rep; 2024 Mar; 9(3):649-660. PubMed ID: 38481516
[TBL] [Abstract][Full Text] [Related]
5. Intrafamilial Variability of ADPKD.
Lanktree MB; Guiard E; Li W; Akbari P; Haghighi A; Iliuta IA; Shi B; Chen C; He N; Song X; Margetts PJ; Ingram AJ; Khalili K; Paterson AD; Pei Y
Kidney Int Rep; 2019 Jul; 4(7):995-1003. PubMed ID: 31317121
[TBL] [Abstract][Full Text] [Related]
6. Polygenic risk alters the penetrance of monogenic kidney disease.
Khan A; Shang N; Nestor JG; Weng C; Hripcsak G; Harris PC; Gharavi AG; Kiryluk K
Nat Commun; 2023 Dec; 14(1):8318. PubMed ID: 38097619
[TBL] [Abstract][Full Text] [Related]
7. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
[TBL] [Abstract][Full Text] [Related]
8. Monoallelic pathogenic
Dordoni C; Zeni L; Toso D; Mazza C; Mescia F; Cortinovis R; Econimo L; Savoldi G; Alberici F; Scolari F; Izzi C
Clin Kidney J; 2024 Feb; 17(2):sfae026. PubMed ID: 38404363
[TBL] [Abstract][Full Text] [Related]
9. Clinical Manifestation and Management of ADPKD in Western Countries.
Sommerer C; Zeier M
Kidney Dis (Basel); 2016 Oct; 2(3):120-127. PubMed ID: 27921039
[TBL] [Abstract][Full Text] [Related]
10. Atypical ADPKD Due to a
Kachmar J; El-Haffaf Z; Bollée G
Can J Kidney Health Dis; 2023; 10():20543581231203054. PubMed ID: 37867501
[TBL] [Abstract][Full Text] [Related]
11. Co-inheritance of pathogenic variants in PKD1 and PKD2 genes presenting as severe antenatal phenotype of autosomal dominant polycystic kidney disease.
Arora V; Bijarnia-Mahay S; Tiwari V; Bansal S; Gupta P; Setia N; Puri RD; Verma IC
Eur J Med Genet; 2020 Mar; 63(3):103734. PubMed ID: 31349084
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.
O'Sullivan DA; Torres VE; Gabow PA; Thibodeau SN; King BF; Bergstralh EJ
Am J Kidney Dis; 1998 Dec; 32(6):976-83. PubMed ID: 9856513
[TBL] [Abstract][Full Text] [Related]
13. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
14. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C
J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China.
Xue C; Zhou CC; Wu M; Mei CL
Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038
[TBL] [Abstract][Full Text] [Related]
16. Co-Inheritance of Pathogenic Variants in
Graziani L; Zampatti S; Carriero ML; Minotti C; Peconi C; Bengala M; Giardina E; Novelli G
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628640
[TBL] [Abstract][Full Text] [Related]
17. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
18. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.
Cornec-Le Gall E; Olson RJ; Besse W; Heyer CM; Gainullin VG; Smith JM; Audrézet MP; Hopp K; Porath B; Shi B; Baheti S; Senum SR; Arroyo J; Madsen CD; Férec C; Joly D; Jouret F; Fikri-Benbrahim O; Charasse C; Coulibaly JM; Yu AS; Khalili K; Pei Y; Somlo S; Le Meur Y; Torres VE; ; ; ; Harris PC
Am J Hum Genet; 2018 May; 102(5):832-844. PubMed ID: 29706351
[TBL] [Abstract][Full Text] [Related]
19. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease.
Rossetti S; Harris PC
J Am Soc Nephrol; 2007 May; 18(5):1374-80. PubMed ID: 17429049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
